Dr. Haifeng Ye received his Ph.D degree and completed his Postdoctoral Research from Swiss Federal Institute of Technology Zurich (ETH Zürich) in the group of Prof. Dr. Martin Fussenegger. He has been awarded the “ETH Silver Medal” at ETH Zürich in 2013. He started his own group in the School of Life Sciences at East China Normal University (ECNU) in 2014 and established the Biomedical Synthetic Biology Center in 2019 at ECNU. His research interest has been focused on synthetic biology and biomedical engineering with the goal to achieve precise diagnosis and treatment of diseases. His research topics include optogenetics-based precision medicine, synthetic gene circuits for gene- and cell-based therapy, synthetic biology-based tumor immunotherapy.
His research work was published in the top scientific journals: Science, Science Translational Medicine, Science Advances, Nature Biotechnology, Nature Biomedical Engineering, Nature Chemical Biology, Nature Communications, Proc Natl Acad Sci USA, Molecular Therapy, etc. His research was also highlighted by a series of scientific journals: Cell, Nature Medicine, Nature Chemical Biology, Nature Reviews Molecular Cell Biology and received international press coverage: Xinhua News Agency, CCTV, BBC, EurekaAlert@AAAS, MIT Technology Review, ScienceDaily, IEEE Spectrum, LE TEMPS, ScienceDaily, FOCUS, Discover, Lab Times, Bioworld, etc.